Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice
Since the first recorded infection of humans with H5N1 viruses of avian origin in 1997, sporadic human infections continue to occur with a staggering mortality rate of >60%. Although sustained human-to-human transmission has not occurred yet, there is a growing concern that these H5N1 viruses might acquire this trait and raise the specter of a pandemic. Despite progress in deciphering viral determinants of pathogenicity, we still lack crucial information on virus/immune system interactions pertaining to severe disease and high mortality associated with human H5N1 influenza virus infections. Using two human isolates of H5N1 viruses that differ in their pathogenicity in mice, we have defined mechanistic links among the rate of viral replication, mortality, CD8 T cell responses, and immunopathology. The extreme pathogenicity of H5N1 viruses was directly linked to the ability of the virus to replicate rapidly, and swiftly attain high steady-state titers in the lungs within 48 hours after infection. The remarkably high replication rate of the highly pathogenic H5N1 virus did not prevent the induction of IFN-β or activation of CD8 T cells, but the CD8 T cell response was ineffective in controlling viral replication in the lungs and CD8 T cell deficiency did not affect viral titers or mortality. Additionally, BIM deficiency ameliorated lung pathology and inhibited T cell apoptosis without affecting survival of mice. Therefore, rapidly replicating, highly lethal H5N1 viruses could simply outpace and overwhelm the adaptive immune responses, and kill the host by direct cytopathic effects. However, therapeutic suppression of early viral replication and the associated enhancement of CD8 T cell responses improved the survival of mice following a lethal H5N1 infection. These findings suggest that suppression of early H5N1 virus replication is key to the programming of an effective host response, which has implications in treatment of this infection in humans.
Vyšlo v časopise:
Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001139
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001139
Souhrn
Since the first recorded infection of humans with H5N1 viruses of avian origin in 1997, sporadic human infections continue to occur with a staggering mortality rate of >60%. Although sustained human-to-human transmission has not occurred yet, there is a growing concern that these H5N1 viruses might acquire this trait and raise the specter of a pandemic. Despite progress in deciphering viral determinants of pathogenicity, we still lack crucial information on virus/immune system interactions pertaining to severe disease and high mortality associated with human H5N1 influenza virus infections. Using two human isolates of H5N1 viruses that differ in their pathogenicity in mice, we have defined mechanistic links among the rate of viral replication, mortality, CD8 T cell responses, and immunopathology. The extreme pathogenicity of H5N1 viruses was directly linked to the ability of the virus to replicate rapidly, and swiftly attain high steady-state titers in the lungs within 48 hours after infection. The remarkably high replication rate of the highly pathogenic H5N1 virus did not prevent the induction of IFN-β or activation of CD8 T cells, but the CD8 T cell response was ineffective in controlling viral replication in the lungs and CD8 T cell deficiency did not affect viral titers or mortality. Additionally, BIM deficiency ameliorated lung pathology and inhibited T cell apoptosis without affecting survival of mice. Therefore, rapidly replicating, highly lethal H5N1 viruses could simply outpace and overwhelm the adaptive immune responses, and kill the host by direct cytopathic effects. However, therapeutic suppression of early viral replication and the associated enhancement of CD8 T cell responses improved the survival of mice following a lethal H5N1 infection. These findings suggest that suppression of early H5N1 virus replication is key to the programming of an effective host response, which has implications in treatment of this infection in humans.
Zdroje
1. GrahamMB
BracialeTJ
1997 Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med 186 2063 2068
2. TophamDJ
TrippRA
DohertyPC
1997 CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 159 5197 5200
3. WoodlandDL
2003 Cell-mediated immunity to respiratory virus infections. Curr Opin Immunol 15 430 435
4. EpsteinSL
LoCY
MisplonJA
BenninkJR
1998 Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol 160 322 327
5. LawrenceCW
BracialeTJ
2004 Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 173 1209 1218
6. LawrenceCW
ReamRM
BracialeTJ
2005 Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 174 5332 5340
7. BenderBS
CroghanT
ZhangL
SmallPAJr
1992 Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175 1143 1145
8. LeeBO
Rangel-MorenoJ
Moyron-QuirozJE
HartsonL
MakrisM
2005 CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J Immunol 175 5827 5838
9. La GrutaNL
KedzierskaK
StambasJ
DohertyPC
2007 A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85 85 92
10. MoskophidisD
KioussisD
1998 Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med 188 223 232
11. EnelowRI
MohammedAZ
StolerMH
LiuAN
YoungJS
1998 Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J Clin Invest 102 1653 1661
12. de JongMD
SimmonsCP
ThanhTT
HienVM
SmithGJ
2006 Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12 1203 1207
13. HattaM
GaoP
HalfmannP
KawaokaY
2001 Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293 1840 1842
14. SubbaraoK
KlimovA
KatzJ
RegneryH
LimW
1998 Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 393 396
15. LuX
TumpeyTM
MorkenT
ZakiSR
CoxNJ
1999 A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 73 5903 5911
16. KatzJM
LuX
TumpeyTM
SmithCB
ShawMW
2000 Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J Virol 74 10807 10810
17. JacksonD
HossainMJ
HickmanD
PerezDR
LambRA
2008 A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105 4381 4386
18. SeoSH
HoffmannE
WebsterRG
2002 Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8 950 954
19. SzretterKJ
GangappaS
BelserJA
ZengH
ChenH
2009 Early control of H5N1 influenza virus replication by the type I interferon response in mice. J Virol 83 5825 5834
20. OpfermanJT
KorsmeyerSJ
2003 Apoptosis in the development and maintenance of the immune system. Nat Immunol 4 410 415
21. MarsdenVS
StrasserA
2003 Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 21 71 105
22. AokiFY
MacleodMD
PaggiaroP
CarewiczO
El SawyA
2003 Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 51 123 129
23. GillissenA
HoffkenG
2002 Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment. Med Microbiol Immunol 191 165 168
24. SchirmerP
HolodniyM
2009 Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opin Drug Saf 8 357 371
25. YenHL
MontoAS
WebsterRG
GovorkovaEA
2005 Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 192 665 672
26. KisoM
TakahashiK
Sakai-TagawaY
ShinyaK
SakabeS
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc Natl Acad Sci U S A 107 882 887
27. ClaasEC
OsterhausAD
van BeekR
De JongJC
RimmelzwaanGF
1998 Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351 472 477
28. CoxNJ
SubbaraoK
2000 Global epidemiology of influenza: past and present. Annu Rev Med 51 407 421
29. CillonizC
ShinyaK
PengX
KorthMJ
ProllSC
2009 Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 5 e1000604
30. NeumannG
ChenH
GaoGF
ShuY
KawaokaY
H5N1 influenza viruses: outbreaks and biological properties. Cell Res 20 51 61
31. LeggeKL
BracialeTJ
2005 Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity 23 649 659
32. FornekJL
Gillim-RossL
SantosC
CarterV
WardJM
2009 A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice. J Virol 83 11102 11115
33. ZhouJ
LawHK
CheungCY
NgIH
PeirisJS
2006 Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages. J Infect Dis 193 945 953
34. MengXW
LeeSH
DaiH
LoegeringD
YuC
2007 Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization. J Biol Chem 282 29831 29846
35. WerneburgNW
GuicciardiME
BronkSF
KaufmannSH
GoresGJ
2007 Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J Biol Chem 282 28960 28970
36. HanJ
GoldsteinLA
GastmanBR
RabinowichH
2006 Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J Biol Chem 281 10153 10163
37. McGillJ
Van RooijenN
LeggeKL
2008 Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med 205 1635 1646
38. TumpeyTM
LuX
MorkenT
ZakiSR
KatzJM
2000 Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 74 6105 6116
39. LiQ
SkinnerPJ
HaSJ
DuanL
MattilaTL
2009 Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323 1726 1729
40. BudhuS
LoikeJD
PandolfiA
HanS
CatalanoG
CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. J Exp Med 207 223 235, S221–224
41. DaidojiT
KomaT
DuA
YangCS
UedaM
2008 H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells. J Virol 82 11294 11307
42. BadovinacVP
PorterBB
HartyJT
2004 CD8+ T cell contraction is controlled by early inflammation. Nat Immunol 5 809 817
43. CillonizC
Pantin-JackwoodMJ
NiC
GoodmanAG
PengX
Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J Virol 84 7613 7624
44. KacergiusT
AmbrozaitisA
DengY
GravensteinS
2006 Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferon-activated RAW 264.7 macrophages. Pharmacol Rep 58 924 930
45. BouilletP
MetcalfD
HuangDC
TarlintonDM
KayTW
1999 Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 1735 1738
46. AndrewsBS
EisenbergRA
TheofilopoulosAN
IzuiS
WilsonCB
1978 Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148 1198 1215
47. Fung-LeungWP
SchilhamMW
RahemtullaA
KundigTM
VollenweiderM
1991 CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65 443 449
48. MartinezX
KreuwelHT
RedmondWL
TrenneyR
HunterK
2005 CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles. J Immunol 175 1677 1685
49. KolumamGA
ThomasS
ThompsonLJ
SprentJ
Murali-KrishnaK
2005 Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202 637 650
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 10
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Retroviral RNA Dimerization and Packaging: The What, How, When, Where, and Why
- Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice
- Antimicrobial Peptides: Primeval Molecules or Future Drugs?
- Crystal Structure of DotD: Insights into the Relationship between Type IVB and Type II/III Secretion Systems